vimarsana.com
Home
Live Updates
AffaMeds Dextenza NDA Accepted In Singapore For Treating Ocular Inflammation And Pain : comparemela.com
AffaMed's Dextenza NDA Accepted In Singapore For Treating Ocular Inflammation And Pain
(RTTNews) - AffaMed Therapeutics said that the Singapore Health Sciences Authority has accepted its New Drug Application or NDA for Dextenza (0.4 ...
Related Keywords
China ,
Singapore ,
Macau ,
South Korea ,
,
Singapore Health Sciences Authority ,
Ocular Therapeutix Inc ,
More Such Health News ,
Amed Therapeutics ,
New Drug Application ,
Mainland China ,
Affamed Therapeutics ,
Ocular Therapeutix ,
Greater China ,
comparemela.com © 2020. All Rights Reserved.